Caroline Stout

Caroline Stout

Chief Investment Officer at PANACEA ACQUISITION CORP. II
35 year
Finance
Health Technology
Consumer Services

Profile

Ms. Caroline C.
Stout
is an Independent Director at Affinia Therapeutics, Inc., a Chief Investment Officer at Panacea Acquisition Corp.
II and a Partner at EcoR1 Capital, LLC.
She is on the Board of Directors at Affinia Therapeutics, Inc. and Neogene Therapeutics, Inc. Ms. Stout joined EcoR1 in 2014 and has led several of the firm’s investments in the biotechnology sector.
She has also served as Chief Investment Officer of Panacea Acquisition Corp I and II.
Prior to joining EcoR1, Ms. Stout worked as an investment banker at Credit Suisse in New York.
Ms. Stout graduated magna cum laude from Georgetown University with a Bachelor of Arts in Economics, a Pre-Medical concentration, and Cognitive Science minor.

Caroline Stout active positions

CompaniesPositionStart
PANACEA ACQUISITION CORP. II Chief Investment Officer 01/01/2021
Analyst-Equity 01/01/2014
Director/Board Member 06/10/2020
Director/Board Member 01/04/2021

Former positions of Caroline Stout

CompaniesPositionEnd
Chief Investment Officer -
See the detail of Caroline Stout's experience

Training of Caroline Stout

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

94

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Consumer Services

Finance

Health Technology

Health Technology

Finance

Finance

  1. Stock Market
  2. Insiders
  3. Caroline Stout